2012
DOI: 10.1021/ja208999e
|View full text |Cite
|
Sign up to set email alerts
|

Structure-Based Design of a Potent Artificial Transactivation Domain Based on p53

Abstract: Malfunctions in transcriptional regulation are associated with a number of critical human diseases. As a result, there is considerable interest in designing artificial transcription activators (ATAs) that specifically control genes linked to human diseases. Like native transcriptional activator proteins, an ATA must minimally contain a DNA-binding domain (DBD) and a transactivation domain (TAD) and, although there are several reliable methods for designing artificial DBDs, designing artificial TADs has proven … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
10
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 84 publications
1
10
0
Order By: Relevance
“…Similar result has been reported for p53 mimetic ECapLL [ 28 ]. We recognized analogical modification of the second p53 9aaTAD-II domain towards the first 9aaTAD motif (in the p53 9aaTAD-I domain) [ 16 ].…”
Section: Discussionsupporting
confidence: 91%
“…Similar result has been reported for p53 mimetic ECapLL [ 28 ]. We recognized analogical modification of the second p53 9aaTAD-II domain towards the first 9aaTAD motif (in the p53 9aaTAD-I domain) [ 16 ].…”
Section: Discussionsupporting
confidence: 91%
“…Importantly, these same studies have shown that the p53 activation domain appears to use a similar structural motif (IExWF). Indeed, the design of an efficient artificial transcription activation domain based on the structural details of the VP16/p53 interaction with TFIIH was recently reported (Langlois et al ., ).…”
Section: Resultsmentioning
confidence: 97%
“…Tfb1PH and CBP KIX were expressed and purified as previously described [39], [55]. EBNA2 431–487 , EBNA2 448–471 and mutants were expressed as GST fusion proteins in E. coli host strain TOPP2, purified over glutathione-sepharose resin (GE Healthcare) and cleaved with thrombin (Calbiochem) as previously described [39].…”
Section: Methodsmentioning
confidence: 99%